Infectious and Thrombotic Complications of Central Venous Catheters

Seminars in Oncology Nursing

Volumn 26, Issue 2, 2010, Pages 121-131

  Nakazawa, Nadine ^a  

^a NONE

Author keywords

catheter related bloodstream infections; catheter related infections; catheter related thrombosis; central venous access devices; Central venous catheters

Indexed keywords

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; EQUIPMENT; HUMAN; INFECTION CONTROL; INSTRUMENTATION; METHODOLOGY; MICROBIOLOGY; NURSE ATTITUDE; NURSING; ONCOLOGY NURSING; PRACTICE GUIDELINE; PRECIPITATION; QUALITY CONTROL; RISK FACTOR; SAFETY; SEPSIS; SKIN; SKIN CARE; THROMBOSIS;

BENCHMARKING; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHEMICAL PRECIPITATION; CROSS INFECTION; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL; NURSE'S ROLE; ONCOLOGIC NURSING; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SAFETY; SEPSIS; SKIN; SKIN CARE; THROMBOSIS;

EID: 77953168877     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2010.02.007     Document Type: Article

References (50)

1. Amesur N, Zajko A, Orons P. Central venous access, emedicine. Updated May 23, 2008. Available at: http://emedicine.medscape.com/article/422189-print. (accessed Dec 18, 2009).
2. Fazeny-Dörner B., Wenzel C., and Berzlanovich A. Central venous catheter pinch-off and fracture: recognition, prevention and management. Bone Marrow Transplant 31 (2003) 927-930
3. Gallieni M., Pittiruti M., and Biffi R. Vascular access in the oncology patient. CA: Cancer J Clin 58 (2008) 323-346
4. Nichols I., and Humphrey J. The efficacy of upper arm placement of peripherally inserted central catheters using bedside ultrasound and microintroducer technique. J Infus Nurs 31 (2008) 165-176
5. Tan P., and Gibson M. Central venous catheters: the role of radiology. Clin Radiol 61 (2006) 13-22
6. National Association of Vascular Access Networks. Tip location of peripherally inserted central catheters. NAVAN position statement. Available at: http://www.avainfo.org:80/website/download.asp?id=1447. (accessed Dec 18, 2009).
7. Cadman A., Lawrance J., Fitzsimmons L., et al. To clot or not to clot? That is the question in central venous catheters. Clin Radiol 59 (2004) 349-355
8. Luciani A., Clement O., Halimi P., et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 220 (2001) 655-660
9. Vesely T. Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol 14 (2003) 527-534
10. In: Camp-Sorrell D. (Ed). Access Devices Guidelines. 2nd edition (2004), Oncology Nursing Society, Pittsburgh, PA
11. Infusion Nursing Society. Infusion nursing standards of practice. J Infus Nurs 29 Suppl (2006) S1-S92
12. Amerasekera S., Jones C., Patel R., et al. Imaging of the complications of peripherally inserted central catheters. Clin Radiol 64 (2009) 832-840
13. Cummings-Winfield C., and Mushani-Kanji Y. Restoring patency to central venous access devices. Clin J Oncol Nurs 12 (2008) 925-934
14. Deitcher S.R., Fesen M.R., Kiproff P.M., et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the Cardiovascular Thrombolytic to Open Occluded Lines trial. J Clin Oncol 20 (2002) 317-324
15. Moreau N., Poole S., Murdock M., et al. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 13 (2002) 1009-1016
16. Campisi C., Biffi R., and Pittiruti M. Catheter-related venous thrombosis: the development of a nationwide consensus paper in Italy. J Assoc Vasc Access 12 (2007) 38-46
17. Mehall J.R., Salzman D.A., Jackson J.R., et al. Fibrin sheath enhances central venous catheter infection. Crit Care Med 4 (2002) 908-912
18. Raad I., Khalil S., Coserton J.W., et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271 (1994) 1014-1016
19. Todar K. The normal bacterial flora of humans. Available at: http://www.textbookofbacteriology.net/normalflora.html. (accessed Jan 2, 2010).
20. Ryder M. Evidence-based practice in the management of vascular access devices for home parenteral nutrition therapy. J Parenter Enteral Nutr 30 (2006) S82-S93
21. Marschall J., Mermel L., Classen D., et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29 (2008) S22-S30
22. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
23. Institute for Healthcare Improvement. Central Line Bundle. Available at: http://www.ihi.org/ihi/search/searchresults.aspx?searchterm=central+line+bundle&searchtype=basic&Start+Search.x=0&Start+Search.y=0. Accessed Dec 20, 2009.
24. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49 (2009) 1-45
25. Safdar N., and Maki D.G. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Int Care Med 30 (2004) 62-67
26. Darouiche R. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 33 (2001) 1567-1572
27. Ryder M. Catheter-related infections: it's all about biofilm. Adv Pract Nurs 5 (2005). http://www.medscape.com/viewarticle/508109 (accessed Jan 2, 2010)
28. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet 7 (2007) 645-657
29. Kaler W., and Chinn R. Successful disinfection of needleless access ports: a matter of time and friction. J Assoc Vasc Access 12 (2007) 140-142
30. Salzman M., Isenberg H., and Rubin L. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 31 (1993) 475-479
31. Menyhay S.Z., and Maki D. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap. Infect Control Hosp Epidemiol 22 (2006) 23-27
32. Hanchett M. Needleless connectors and bacteremia: is there a relationship? Infection Control Today. Available at: http://www.infectioncontroltoday.com/articles/410/410_5b1feat2.html. (accessed Jan 2, 2010).
33. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet1991;338:339-343.
34. Hibbard J. Analyses comparing the antimicrobial activity and safety of current antiseptic agents: a review. J Infus Nurs 28 (2005) 195-207
35. Timset J., Schwebel C., Bouadma L., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults. JAMA 301 (2009) 1231-1241
36. Rushulte H., Franke M., Gastmeier P., et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 88 (2009) 267-272
37. Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp#TopOfPage. (accessed Jan 2, 2010).
38. Murphy D, Whiting J. Dispelling the myths: the true cost of healthcare-associated infections. Available at: http://www.premierinc.com/safety/topics/guidelines/downloads/09-hai-whitepaper.pdf (accessed Jan 2, 2010).
39. Saint S. Prevention of intravascular catheter-associated infections, making health care safer: a critical analysis of patient safety practices. Available at: http://www.ahrq.gov/clinic/ptsafety/chap16a.htm. (accessed Jan 24, 2010).
40. Stephens L., Haire W., and Kotulak G. Are clinical signs accurate indicators of the cause of central venous catheter occlusion?. J Parent Enter Nutr 19 (1995) 75-79
41. Schulmeister L.L., and Camp-Sorrell D. Chemotherapy extravasation from implanted ports. Oncol Nurs Forum 3 (2000) 531-538
42. Polovich M., White J., and Kelleher L. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (2005), Oncology Nursing Society, Pittsburgh, PA
43. Ponec D., Irwin D., Haire W.D., et al. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 12 (2001) 951-955
44. Blaney M., Shen V., Kerner J., et al. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (the Cathflo Activase Pediatric Study). J Vasc Interv Radiol 17 (2006) 1745-1751
45. Werlin S.L., Lausten T., Jessen S., et al. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid. J Paren Enter Nutr 19 (1995) 416-418
46. Cohen MH, Johnston-Hood A, Hood MA, et al. Drug precipitation within i.v. tubing: a potential hazard of chemotherapy administration. Cancer Treat Rep1985;69:1325-1326.
47. Davis's Drug Guide.com. Amphotericin B deoxycholate. Available at: http://www.drugguide.com/ddo/ub/view/Davis-Drug-Guide/51050/11/amphotericin_B_deoxycholate. (accessed Jan 24, 2010).
48. GlobalpH.com. Rifampin. Available at: http://www.globalrph.com/rifampin_dilution.htm. Phenytoin. Available at: http://www.globalrph.com/phenytoin_dilution.htm. (accessed Jan 24, 2010).
49. Murney P. To mix or not to mix - compatibilities of parenteral drug solutions. Aust Prescriber 31 (2008) 98-101
50. Williams D.A., and Lokich J. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions. Cancer Chemother Pharmacol 31 (1992) 171-181